Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 16-19 September 2024 European Medicines Agency | Nawigacja wpisu High-throughput identification of repurposable neuroactive drugs with potent anti-glioblastoma activity – Nature.com This experimental lung cancer drug outperforms blockbuster medicine Keytruda. But there’s a catch – ThePrint
